Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report)’s stock price hit a new 52-week high on Tuesday . The stock traded as high as $9.64 and last traded at $9.64, with a volume of 1001 shares trading hands. The stock had previously closed at $8.80.
Aspen Pharmacare Stock Performance
The company has a debt-to-equity ratio of 0.36, a current ratio of 3.64 and a quick ratio of 2.66. The stock has a fifty day simple moving average of $9.08 and a two-hundred day simple moving average of $8.61.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over‐the‐counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Stories
- Five stocks we like better than Aspen Pharmacare
- 3 Stocks Built for Higher Rates—And 2 That Could Break
- Safety Stocks Are Not What They Used to Be: 4 Names Built for a Weaker Dollar
- 3 AI Optical Networking Stocks Positioned for the Data Center Buildout
- 5 Defensive Stocks to Watch as CPI and the Fed Put the Rally to the Test
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
